World Scan Project, INC 10-Q quarterly reports

World Scan Project, Inc. reported a significant reduction in net loss for the nine months ended July 31, 2025, despite a revenue decline, while cash balances decreased substantially.

World Scan Project, Inc. filed an amendment to its Q1 2025 report to correct a clerical error in preferred shares outstanding and update the signature date, with no other changes to the original filing.

World Scan Project, Inc. reported a shift to net income for the six months ended April 30, 2025, alongside a significant reduction in liabilities and a capital raise, despite a decline in overall revenue.

World Scan Project, Inc. reported a net income of $101,969 for the first quarter ended January 31, 2025, a significant improvement from a net loss in the prior year, despite a decrease in overall revenue.

World Scan Project, Inc. filed an amended quarterly report to restate revenue recognition for crypto miner sales from a net to a gross basis, impacting financial metrics and revealing ongoing capital raises.

World Scan Project, Inc. filed an amended quarterly report, restating revenue to a gross basis and revealing a significant decline in sales and a shift to net loss.

World Scan Project, Inc. filed an amended quarterly report for Q1 2024, restating revenue to a gross basis and reporting a significant net loss and negative operating cash flow.

World Scan Project's Q3 2024 results show a significant decrease in revenue compared to the same period last year, but also a substantial increase in working capital.

World Scan Project's Q2 2024 results show a significant decrease in revenue and a net loss, but also an increase in working capital and a successful capital raise.

World Scan Project restated its Q3 financials due to a revenue recognition error related to crypto miner sales, while also reporting a net loss driven by significant research and development expenses.

World Scan Project's Q1 2024 results show a net loss and decreased cash flow from operations, primarily due to increased advance payments and R&D expenses, despite a significant increase in revenue compared to the same period last year.